Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/smad signaling in DOCA-salt hypertension

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1204-1212

  Wang, Youping ^a   Wang, Donna H ^b  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DEOXYCORTICOSTERONE ACETATE; FIBRONECTIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TELEMETRY; WILD TYPE;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; FIBRONECTINS; FIBROSIS; HEART RATE; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY GLOMERULUS; MICE; PHOSPHORYLATION; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD2 PROTEIN; SMAD3 PROTEIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRPV CATION CHANNELS;

EID: 82855168152     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00063     Document Type: Article

References (41)

1. Atkins RC. (2005) The epidemiology of chronic kidney disease. Kidney Int. 94:S14-18.
2. Hartner A, Veelken R, Wittmann M, Cordasic N, Hilgers KF. (2005) Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrol. 6:6.
3. Eddy AA. (2000) Molecular basis of renal fibrosis. Pediatr. Nephrol. 15:290-301.
4. Mason RM, Wahab NA. (2003) Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14:1358-73.
5. Wang W, Koka V, Lan HY. (2005) Transforming growth factor-β and Smad signaling in kidney disease. Nephrology. (Carlton) 10:48-56.
6. Chabrier PE. (1996) Growth factors and vascular wall. Int. Angiol. 15:100-3.
7. Kretzschmar M, Massague J. (1998) SMADs: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8:103-11.
8. Spriewald BM, Ensminger SM, Billing JS, Morris PJ, Wood KJ. (2003) Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Transplantation. 76:1105-11.
9. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. (2003) Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J. Vasc. Res. 40:37-46.
10. Mata-Greenwood E, Meyrick B, Steinhorn RH, Fineman JR, Black SM. (2003) Alterations in TGFbeta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am. J. Physiol. 285:L209-21.
11. Porreca E, et al. (1997) Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension. 30:134-9.
12. Caterina MJ, et al. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:306-13.
13. Szallasi A, Blumberg PM. (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51:159-212.
14. Julius D, Basbaum AI. (2001) Molecular mechanisms of nociception. Nature. 413:203-10.
15. Wang Y, Kaminski NE, Wang DH. (2005) VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension. 46:986-91.
16. Wang Y, Kaminski NE, Wang DH. (2007) Endocannabinoid regulates blood pressure via activation of the TRPV1 in Wistar rats fed a high-salt diet. J. Pharmacol. Exp. Ther. 321:763-9.
17. Wang Y, Babánková D, Huang J, Swain GM, Wang DH. (2008) Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension. 52:264-70.
18. Saito T, Sumithran E, Glasgow EF, Atkins RC. (1987) The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int. 32:691-9.
19. Shih W, Hines WH, Neilson EG. (1988) Effects of cyclosporin A on the development of immunemediated interstitial nephritis. Kidney Int. 33:1113-8.
20. Wang YP, et al. (2002) Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc. Res. 56:33-42.
21. Mundel P, Shankland SJ. (2002) Podocyte biology and response to injury. J. Am. Soc. Nephrol. 13:3005-15.
22. Kerjaschki D. (2001) Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J. Clin. Invest. 108:1583-7.
23. Ying WZ, Sanders PW. (2003) The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension. Am. J. Physiol. 285:F902-8.
24. Socha MJ, Manhiani M, Said N, Imig JD, Motamed K. (2007) Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am. J. Pathol. 171:1104-12.
25. Zhu S, Liu Y, Wang L, Meng QH. (2008) Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol. Dial. Transplant. 23:2841-6.
26. Ziyadeh FN, et al. (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 97:8015-20.
27. Matsuda H, et al. (2006) Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. J. Am. Soc. Nephrol. 17:422-32.
28. Ellmers LJ, et al. (2008) Transforming growth factor- beta blockade down-regulates the reninangiotensin system and modifies cardiac remodeling after myocardial infarction. Endocrinology. 149:5828-34.
29. Shi Y, Massagué J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 113:685-700.
30. Bertolino P, Deckers M, Lebrin F, ten Dijke P. (2005) Transforming growth factor-β signal transduction in angiogenesis and vascular disorders. Chest. 128:585S-90S.
31. Abe H, et al. (2004) Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation. J. Biol. Chem. 279:14201-6.
32. Matsubara T, et al. (2006) Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Invest. 86:357-68.
33. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M. (2007) Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem. 282:10405-13.
34. Jones LK, et al. (2009) IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol. Dial. Transplant. 24:3024-32.
35. Keophiphath M, et al. (2009) Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol. Endocrinol. 23:11-24.
36. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen. 16:585-601.
37. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am. J. Physiol. 286:F606-16.
38. Muller DN, et al. (2002) Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am. J. Pathol. 161:1679-93.
39. Elmarakby AA, et al. (2007) Chemokine receptor 2b inhibition provides renal protection in angiotensin II-salt hypertension. Hypertension. 50:1069-76.
40. Wang Y, Wang DH. (2009) Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am. J. Physiol. 297:F1550-9.
41. Wang Y, Chen AF, Wang DH. (2006) Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nerves. Am. J. Physiol. 291:H3136-43.